Historial de carrera de David S. Arrington
Antiguos cargos conocidos de David S. Arrington.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ACHAOGEN | Contacto de Relaciones con Inversores | 01/07/2017 | 01/04/2018 |
| Public Communications Contact | 01/07/2017 | 01/04/2018 | |
| FREELINE THERAPEUTICS HOLDINGS PLC | Contacto de Relaciones con Inversores | - | - |
| Public Communications Contact | - | - | |
| COHERUS BIOSCIENCES, INC. | Contacto de Relaciones con Inversores | 01/09/2018 | - |
| Public Communications Contact | 01/09/2018 | - |
Formación de David S. Arrington.
| Washington State University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 4 |
| Reino Unido | 2 |
Operativa
| Investor Relations Contact | 3 |
| Public Communications Contact | 3 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| COHERUS BIOSCIENCES, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Freeline Therapeutics Holdings Plc
 Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- David S. Arrington
- Experiencia
